Get the Stockscreener App
3.96
1.98%
-0.08
Organogenesis Holdings Inc stock is traded at $3.96, with a volume of 546.47K.
It is down -1.98% in the last 24 hours and down -18.52% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.04
Open:
$4.06
24h Volume:
546.47K
Relative Volume:
0.74
Market Cap:
$502.36M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
110.92
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
-7.69%
1M Performance:
-18.52%
6M Performance:
+5.60%
1Y Performance:
+36.55%
1-Day Range:
$3.89
$4.10
1-Week Range:
$3.89
$4.35
52-Week Range:
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.96 | 512.51M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Is Organogenesis Holdings Inc. trending in predictive chart modelsPortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
What the charts say about Organogenesis Holdings Inc. todayJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
Wealth Enhancement Advisory Services LLC Sells 9,075 Shares of Organogenesis $ORGO - Defense World
Does Organogenesis Holdings Inc. fit your quant trading model2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
Is Organogenesis Holdings Inc. stock ready for a breakout2025 Market WrapUp & High Accuracy Trade Signal Alerts - newser.com
Organogenesis (NASDAQ:ORGO) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Organogenesis Holdings Inc. stock prediction for this week2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Can trapped investors hope for a rebound in Organogenesis Holdings Inc.Trade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
Will Organogenesis Holdings Inc. stock go up soonPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Will Organogenesis Holdings Inc. (2PQ) stock sustain bullish trend into 2025Quarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
How buyback programs support Organogenesis Holdings Inc. (2PQ) stockMarket Activity Summary & Real-Time Stock Price Movement Reports - newser.com
Organogenesis Holdings Inc. stock daily chart insightsWeekly Loss Report & Safe Capital Growth Tips - newser.com
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - PR Newswire
What analysts say about Organogenesis Holdings Inc 2PQ stockMarket Profile Overview & High Return Investment Ideas - earlytimes.in
Will Organogenesis Holdings Inc. continue its uptrendWall Street Watch & Verified Trade Idea Suggestions - newser.com
Will Organogenesis Holdings Inc. stock see PE expansionJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock considered safe havenVolume Spike & Pattern Based Trade Signal System - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationJuly 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com
Does Organogenesis Holdings Inc. qualify in momentum factor screeningTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Using portfolio simulators with Organogenesis Holdings Inc. includedWatch List & Target Return Focused Picks - newser.com
Measuring Organogenesis Holdings Inc.’s beta against major indicesPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Organogenesis $ORGO Shares Sold by Voya Investment Management LLC - Defense World
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025 - The Manila Times
Leading Regenerative Medicine Company Organogenesis to Present Q3 2025 Financial Results and Corporate Update - Stock Titan
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial - MSN
How to monitor Organogenesis Holdings Inc. with trend dashboardsWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organogenesis Holdings Inc Stock (ORGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 05 '25 |
Buy |
2.91 |
142,379 |
413,625 |
837,437 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):